Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available, according to Mittal. In the 2022 clinical trial, tirzepatide showed ...

You can use Wegovy (semaglutide) as long as you need for weight loss and weight management. You can continue taking Wegovy if you and your doctor determine that Wegovy is safe for you and you can ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Prescription weight loss medications ... are two different brands of the same drug, semaglutide. However, there are differences in the recommended dosage and how each is administered.

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...